Alpine Immune Sciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
DECHENG CAPITAL LLC | 05/14/2024 | 8.32 M | $329.72 M | 17.43% | 12.99% |
AVORO CAPITAL ADVISORS LLC | 05/15/2024 | 5.78 M | $228.92 M | 100.00% | 9.02% |
BLACKROCK INC. | 05/10/2024 | 3.58 M | $141.72 M | 16.89% | 5.58% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2024 | 3.13 M | $124.11 M | 0.00% | 4.89% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2024 | 3.08 M | $122.10 M | 82.56% | 4.81% |
STATE STREET CORP | 05/15/2024 | 2.85 M | $112.81 M | 104.73% | 4.44% |
VANGUARD GROUP INC | 05/10/2024 | 2.71 M | $107.51 M | 21.37% | 4.24% |
CORMORANT ASSET MANAGEMENT, LP | 05/15/2024 | 2.70 M | $107.03 M | 5.88% | 4.22% |
ORBIMED ADVISORS LLC | 05/15/2024 | 2.68 M | $106.25 M | 5.73% | 4.19% |
LYNX1 CAPITAL MANAGEMENT LP | 05/15/2024 | 2.25 M | $89.32 M | -40.92% | 3.52% |
PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2024 | 2.12 M | $84.08 M | -33.23% | 3.31% |
DARWIN GLOBAL MANAGEMENT, LTD. | 05/15/2024 | 1.98 M | $78.57 M | 100.00% | 3.10% |
COMMODORE CAPITAL LP | 05/15/2024 | 1.38 M | $54.51 M | -14.60% | 2.15% |
OCTAGON CAPITAL ADVISORS LP | 05/15/2024 | 1.24 M | $49.21 M | 0.00% | 1.94% |
AVIDITY PARTNERS MANAGEMENT LP | 05/15/2024 | 1.17 M | $46.57 M | 100.00% | 1.83% |
GREAT POINT PARTNERS LLC | 05/15/2024 | 1.13 M | $44.73 M | -69.53% | 1.76% |
FRANKLIN RESOURCES INC | 05/13/2024 | 1.09 M | $43.33 M | -10.42% | 1.71% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2024 | 910.60 K | $36.10 M | 19.13% | 1.42% |
MORGAN STANLEY | 10/17/2024 | 789.65 K | $31.30 M | 9.87% | 1.23% |
TWO SIGMA ADVISERS, LP | 05/15/2024 | 668.78 K | $26.51 M | 153.25% | 1.04% |
VIVO CAPITAL, LLC | 04/22/2024 | 520.51 K | $20.79 M | -36.47% | 0.81% |
TWO SIGMA INVESTMENTS, LP | 05/15/2024 | 519.97 K | $20.61 M | 37.41% | 0.81% |
NUVEEN ASSET MANAGEMENT, LLC | 05/13/2024 | 513.18 K | $20.34 M | 294.85% | 0.80% |
FIRST LIGHT ASSET MANAGEMENT, LLC | 05/15/2024 | 501.24 K | $19.87 M | 100.00% | 0.78% |
JANUS HENDERSON GROUP PLC | 05/15/2024 | 450.83 K | $17.84 M | -22.70% | 0.70% |
D. E. SHAW & CO., INC. | 05/15/2024 | 428.56 K | $16.99 M | 45.01% | 0.67% |
CANDRIAM S.C.A. | 05/06/2024 | 415.00 K | $16.45 M | -11.70% | 0.65% |
EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2024 | 408.54 K | $16.19 M | 100.00% | 0.64% |
ARTAL GROUP S.A. | 05/17/2024 | 405.78 K | $16.09 M | 699.43% | 0.63% |
BALYASNY ASSET MANAGEMENT L.P. | 05/13/2024 | 373.00 K | $14.79 M | 100.00% | 0.58% |
VESTAL POINT CAPITAL, LP | 05/14/2024 | 350.00 K | $13.87 M | 100.00% | 0.55% |
NORTHERN TRUST CORP | 05/14/2024 | 341.70 K | $13.55 M | 15.17% | 0.53% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2024 | 339.14 K | $13.44 M | 14.02% | 0.53% |
BANK OF NEW YORK MELLON CORP | 04/25/2024 | 325.94 K | $12.92 M | 218.45% | 0.51% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2024 | 310.00 K | $12.29 M | -56.62% | 0.48% |
INVESCO LTD. | 05/14/2024 | 272.63 K | $10.81 M | 12.76% | 0.43% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2024 | 267.23 K | $10.59 M | 14.32% | 0.42% |
NAN FUNG GROUP HOLDINGS LTD | 05/14/2024 | 263.94 K | $10.46 M | 0.00% | 0.41% |
IKARIAN CAPITAL, LLC | 05/17/2024 | 261.37 K | $10.36 M | -46.36% | 0.41% |
ATIKA CAPITAL MANAGEMENT LLC | 05/14/2024 | 256.00 K | $10.15 M | 100.00% | 0.40% |
WOODLINE PARTNERS LP | 05/15/2024 | 254.33 K | $10.08 M | -74.57% | 0.40% |
RENAISSANCE TECHNOLOGIES LLC | 05/13/2024 | 244.98 K | $9.71 M | 13.06% | 0.38% |
GOLDMAN SACHS GROUP INC | 05/15/2024 | 240.44 K | $9.53 M | 21.47% | 0.38% |
FMR LLC | 05/13/2024 | 238.56 K | $9.46 M | 0.01% | 0.37% |
RAFFERTY ASSET MANAGEMENT, LLC | 05/13/2024 | 234.63 K | $9.30 M | 192.69% | 0.37% |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2024 | 230.00 K | $9.12 M | 100.00% | 0.36% |
CITIGROUP INC | 05/10/2024 | 207.50 K | $8.23 M | 479.97% | 0.32% |
WALLEYE CAPITAL LLC | 05/15/2024 | 206.10 K | $8.17 M | -43.68% | 0.32% |
DEUTSCHE BANK AG\ | 06/02/2025 | 204.48 K | $8.11 M | 57.92% | 0.32% |
BANK OF AMERICA CORP /DE/ | 05/15/2024 | 202.41 K | $8.02 M | 120.58% | 0.32% |
Alpine Immune Sciences, Inc. institutional Ownership - FAQ's
During the previous two years, 7 institutional investors and hedge funds held shares of Alpine Immune Sciences, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 0
CREDIT SUISSE AG/: 32,211
Ziegler Capital Management, LLC: 23,982
Point72 Middle East FZE: 7,900
Decheng Capital Management III (Cayman), LLC: 6.71 M
Amalgamated Financial Corp.: 1,891
100.87% of Alpine Immune Sciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6.77 M shares in the last 24 months. This purchase volume represents approximately $440.12 M in transactions.